IN BRIEF: Hikma Pharmaceuticals appoints ViiV's Rebecca Hall as CFO

Related news

Hikma Pharmaceuticals PLC - London-based pharmaceutical maker - Appoints Rebecca Hall as chief financial officer, effective from a to-be-announced date in the first quarter of 2027, which Hikma will confirm "in due course." Hall joins Hikma from ViiV Healthcare Ltd, a specialist HIV pharmaceutical company majority owned by GSK PLC, with pharma firm Shionogi & Co Ltd as a shareholder. At ViiV Healthcare, Hall is senior vice president and CFO, responsible for finance, supply chain and business development. Hikma Chair Victoria Hull said: "Becky's appointment is a further step in broadening the expertise we have across both the executive team and the board, positioning us well for long-term sustainable growth."

Current stock price: 1,598.00 pence each, up 0.2% on Thursday morning in London

12-month change: down 0.9%

Copyright 2026 Alliance News Ltd. All Rights Reserved.

Directors

Ways to help you invest your money

Our investment accounts

Put your money to work with our range of investment accounts. Choose from ISAs, pensions, and more.

Need some investment ideas?

Let us give you a hand choosing investments. From managed funds to favourite picks, we’re here to help.

Read our expert tips and insights

Our investment experts share their knowledge on how to keep your money working hard across the markets.